Central venous catheter outcomes in nocturnal hemodialysis

Kidney International

Volumn 70, Issue 7, 2006, Pages 1348-1354

  Perl, J ^a   Lok, C E ^a,b   Chan, C T ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Central venous catheter; Nocturnal home hemodialysis; Vascular access complications

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; CANNULATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POISSON DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL; TREATMENT OUTCOME; VASCULAR ACCESS;

ADULT; AGED; CATHETERIZATION, CENTRAL VENOUS; DATA INTERPRETATION, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; HEMODIALYSIS, HOME; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748943825     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001744     Document Type: Article

References (40)

1. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001; 37: s137-s181.
2. Dhingra RK, Young EW, Hulber-Shearon TE et al. Type of vascular access and mortality in US hemodialysis patients. Kidney Int 2001; 60: 1443-1451.
3. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62: 620-626.
4. Xue JL, Dahl D, Ebben JP, Collins AJ. The association of initial hemodialysis access type with mortality outcomes in elderly medicare ESRD patients. Am J Kidney Dis 2003; 42: 1013-1019.
5. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15: 477-486.
6. Astor BC, Eustace JA, Powe NR et al. The CHOICE study type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol 2005; 16: 1449-1455.
7. Schwab SJ, Quarles LD, Middleton JP et al. Hemodialysis-associated subclavian vein stenosis. Kidney Int 1988; 33: 1156-1159.
8. Bander SJ, Schwab SJ. Central venous angioaccess for hemodialysis and its complications. Semin Dial 1992; 5: 121-128.
9. Schwab SJ, Buller GL, McCann RL et al. Prospective evaluation of a dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis 1988; 11: 166-169.
10. Caruana RJ, Raja RM, Zeit RM et al. Thrombotic complications of indwelling central catheters used for chronic hemodialysis. Am J Kidney Dis 1987; 9: 497-501.
11. Uldall R, Ouwendyk M, Francoeur R et al. Slow nocturnal home hemodialysis at the Wellesely Hospital. Adv Renal Replacement Ther 1996; 3: 133-136.
12. Uldall R, DeBruyne M, Besley M et al. A new vascular access catheter for hemodialysis. Am J Kidney Dis 1993; 21: 270-277.
13. Canadian Organ Replacement Registry (CORR)/Canadian Institute for Health Information Nationwide Survey of Prevalent HD patients by vascular access type, Oct 2002.
14. Rayner HC, Besarab A, Brown WW et al. Vascular access results from the dialysis outcomes and practice patterns study (DOPPS): performance against kidney disease outcomes quality initiative (K/DOQI) clinical practice guidelines. Am J Kidney Dis 2004; 44(5 Suppl 3): 22-26.
15. Allon M, Ornt DB, Schwab SJ et al. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Kidney Int 2000; 58: 2178-2185.
16. Ting GO, Kjellstrand C, Freitas T et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42: 1020-1035.
17. Pinciarolli AR. Results of daily hemodialysis in catanzaro: 12-year experience with 22 patients treated for more than one year. Home Hemodial Int 1998; 2: 12-17.
18. Quintaliani G, Buoncristiani U, Fagugli R, et al. Survival of vascular access during daily and three times a week hemodialysis. Clin Nephrol 2000; 53: 372-377.
19. Piccoli GB, Bermond F, Mezza E et al. Vascular access survival and morbidity on daily dialysis: a comparative analysis of home and limited care haemodialysis. Nephrol Dial Transplant 1998; 13: 2853-2860.
20. Ting GO. Blood access outcomes associated with short daily hemodialysis. Hemodial Int 2000; 4: 42-46.
21. Traeger J, Galland R, Delawari E et al. Six years' experience with short daily hemodialysis:do the early improvements persist in the mid and long term? Hemodial Int 2004; 8: 151-158.
22. Pierratos A, Goluboff D, Ouwendyk M. Vascular access for nocturnal hemodialysis. J Am Soc Nephrol 1999; 10: 215A.
23. Pierratos A, Ouwendyk M. Nocturnal hemodialysis: five years later. Semin Dial 1999; 12:6: 419-423.
24. Lockridge R, Spencer M, Craft V, Pipkin M. Six years of experience with nightly home hemodialysis access. Hemodial Int 2004; 8: 349-353.
25. Kiellstrand CM, Blagg CR, Twardowski ZJ, Bower J. Blood access and daily hemodialysis: clinical experience and review of the literature. ASAIO J 2003; 49: 645-649.
26. Lindsay RM, Leitch R, Heidenheim PA, Kortas C. The London daily/nocturnal hemodialysis study - study design, morbidity, and mortality results. Am J Kidney Dis 2003; 42(Suppl 1): S5-S12.
27. Little MA, O'Riordan A, Lucey B et al. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001; 16: 2194-2200.
28. Kairaitis LK, Gottlieb T. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant 1999; 14: 1710-1714.
29. Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10: 1045-1049.
30. Weijmer MC, ter Wee PM. Temporary vascular access for hemodialysis treatment. Current guidelines and future directions. Contrib Nephrol 2002; 137: 38-45.
31. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-1124.
32. Angle JF, Shilling AT, Schenk WG et al. Utility of percutaneous intervention in the management of tunneled hemodialysis catheters. Cardiovasc Intervent Radiol 2003; 26: 9-18.
33. Canaud B, Beraud JJ, Joyeux H, Mion C. Internal jugular vein cannulation with two silicone rubber catheters: a new and safe temporary vascular access for hemodialysis. Thirty months' experience. Artif Organs 1986; 10: 397-403.
34. Moss AH, Vasilakis C, Holley JL et al. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16: 211-215.
35. Suchoki P, Conlon P, Knelson M et al. Silastic cuffed catheters for hemodialysis vascular access: thrombolytic and mechanical correction of HD catheters malfunction. Am J Kidney Dis 1996; 28: 379-386.
36. Lund GB, Trerotola SO, Scheel PF et al. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology 1996; 198: 467-472.
37. Sagripanti A, Cupisti A, Baicehi U et al. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993; 63: 273-278.
38. Lai KN, Yin JA, Yuen PM, Li PK. Effect of hemodialysis on protein C. protein 5, and antithrombin III levels. Am J Kidney Dis 1991; 17: 38-42.
39. Ethier J, Lindsay RM, Barre PE et al. Chapter 3: clinical practice guidelines for vascular access. J Am soc Nephrol 1999; 10: s287-s321.
40. Preventing infections associated with indwelling intravascular access devices. Cancer Commun Dis Rep 1997; 23S8: 1-7.